GRM5 and fragile X syndrome: In the zebrafish model of Fragile X syndrome, pharmacological mGluR5 inhibition corrects neurite branching defects37; whereas in mice, deletion of mGluR5 in layer 2/3 pyramidal neurons of somatosensory cortex impairs dendritic arborization38.